Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anbio Biotechnology

49.86
+0.47000.95%
Post-market: 49.70-0.1600-0.32%16:10 EDT
Volume:87.45K
Turnover:4.43M
Market Cap:2.19B
PE:888.66
High:52.93
Open:49.20
Low:47.41
Close:49.39
52wk High:55.65
52wk Low:5.18
Shares:43.89M
Float Shares:39.69M
Volume Ratio:0.85
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0561
EPS(LYR):0.0561
ROE:14.83%
ROA:7.18%
PB:127.30
PE(LYR):888.66

Loading ...

Company Profile

Company Name:
Anbio Biotechnology
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
27
Office Location:
Wilhelm Gutbrod Str 21B,Frankfurt am Main,Hessen,Germany
Zip Code:
60437
Fax:
- -
Introduction:
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. Its research and development activities for all IVD products: Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer. Its product AF-1200 Fluorescence Immunoassay Analyzer, AF-100 Fluorescence Immunoassay Analyzer, AF-100S Fluorescence Immunoassay Analyzer, AF-100C Fluorescence Immunoassay Analyzer.

Directors

Name
Position
David Hsu
Independent Director
Kenneth Li
Independent Director
Nancy Hartzler
Independent Director
Cany Xu
Director

Shareholders

Name
Position
Michael Lau
Chief Executive Officer
Suki Song
Chief Financial Officer
Chris Tian
Chief Business Officer